Humana Hit With Investor Suit Over Post-COVID Costs

By Katryna Perera · June 3, 2024, 10:06 PM EDT

Health insurer Humana and two executives were hit with an investor class action on Monday, claiming they misled shareholders about the cost of pent-up demand for medical treatments once the COVID-19...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Complaint

Case Information

Case Title

Iron Workers Local 401 Annuity Fund v. Humana Inc. et al

Case Number

Court

Delaware

Nature of Suit

Securities/Commodities

Date Filed

June 03, 2024

Recent Articles By Katryna

July 01, 2024
Delta Dental Wants Antitrust Claims Standard Decided Now
June 06, 2024
White Collar Boutique Sued By Ex-Client Over Representation
June 04, 2024
Biotech RenovaCare Can't Beat Investors' Stock Promo Suit
May 30, 2024
Veradigm Execs Sued Over Company's Nasdaq Delisting
May 20, 2024
iRhythm Brass Face Suit Over FDA's Heart Monitor Inquiry
May 02, 2024
Masimo Hit With Derivative Suit Over Audio Co. Acquisition
May 01, 2024
Insulin Pump Maker Wins Toss of Investor Suit For Now
April 30, 2024
Vaxart Investors Want Sanctions Over Deleted Texts
April 08, 2024
Walmart Beats Investor Suit Over Opioid Probe Disclosures
March 29, 2024
Hedge Fund Beats Vaxart Investor's 'Short-Swing' Profits Suit